Come True Biomedical Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 7.78 million compared to TWD 9.56 million a year ago. Revenue was TWD 7.78 million compared to TWD 9.56 million a year ago. Net income was TWD 0.541 million compared to net loss of TWD 2.16 million a year ago. Basic earnings per share from continuing operations was TWD 0.02 compared to basic loss per share from continuing operations of TWD 0.07 a year ago.